RTP Mobile Logo

Thursday, May 17, 2018, Washington, DC, 12:15 PM – 1:45 PM

Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice — A 6-Part CNE Symposia Series Held During the 43rd Annual ONS Congress

PART 3 — PARP Inhibition in the Management of Ovarian Cancer

Event Details

Marriott Marquis Washington, DC
901 Massachusetts Ave NW
Washington, DC 20001
Hotel Phone: (202) 824-9200

Meeting Room:
Independence A-E (Meeting Level 4)
Schedule (EST):
11:45 AM – 12:15 PM
Registration and Lunch Buffet

12:15 PM – 1:45 PM
Educational Program
There is no registration fee for this event. Preregistration is highly recommended as seating and meal service are limited.

Paula J Anastasia, RN, MN, AOCN
Gyn-Oncology Clinical Nurse Specialist
Cedars-Sinai Medical Center
Los Angeles, California

Deborah K Armstrong, MD
Director, Breast and Ovarian Surveillance Service
Professor of Oncology, Gynecology and Obstetrics
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, Maryland

Michael Birrer, MD, PhD
Director, UAB Comprehensive Cancer Center
University of Alabama at Birmingham
Birmingham, Alabama

Additional faculty to be announced
Neil Love, MD
Research To Practice
Miami, Florida
Meeting space has been assigned to provide a symposium supported by AstraZeneca Pharmaceuticals LP, Clovis Oncology and Tesaro Inc during the Oncology Nursing Society’s (ONS) 43rd Annual Congress, May 16-20, 2018 in Washington, DC. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement.


Cases Presented Will Include Discussion of the Following Topics:

  • MODULE 1: Genetic Testing in Ovarian Cancer (OC)
  • MODULE 2: Contemporary Clinical Algorithms in OC
  • MODULE 3: Practical Integration of PARP Inhibitors into the Care of Patients with Recurrent OC

CE Information

Target Audience:
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of ovarian cancer (OC).

Learning Objectives:
Upon completion of this activity, participants should be able to:

  • Demonstrate knowledge of existing guidelines and consensus statements regarding the rationale for genetic testing and counseling for all patients with newly diagnosed OC regard­less of family history.
  • Appreciate available clinical trial data with and approved indications for FDA-endorsed PARP inhibitors to appropriately integrate these agents into the routine care of patients with OC.
  • Understand the dosing requirements and other practical considerations for the use of PARP inhibitors for women with OC to ensure appropriate administration and patient compliance.
  • Describe the potential toxicities of FDA-approved PARP inhibitors, and use this information to design effective monitoring strategies for patients receiving these agents.
  • Develop an evidence-based algorithm for the prevention and amelioration of side effects associ­ated with the use of PARP inhibitors for the treatment of platinum-sensitive and platinum-recurrent advanced OC.
  • Review available efficacy data and the associated toxicity profiles of investigational PARP inhibi­tors to effectively prioritize clinical trial opportunities for appropriate patients with OC.
  • Identify opportunities to enhance the collaborative role of oncology nurses in the comprehensive biopsychosocial care of patients with OC to optimize clinical and quality-of-life outcomes.
Accreditation Statement:
Research To Practice is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation Statements:
This educational activity for 1.5 contact hours is provided by Research To Practice.

This activity is awarded 1.5 ANCC pharmacotherapeutic contact hours.

To obtain a certificate of completion and receive credit for this event, nurses must sign in at the registration desk upon arrival, attend the entire activity and return a completed Educational Assessment and Credit Form upon exiting the activity.

ONC/ILNA Certification:
This activity will be submitted to the ONCC for ILNA verification.

Unlabeled/Unapproved Uses Notice:
There is no implied or real endorsement of any product by Research To Practice or the American Nurses Credentialing Center. Any off-label use as declared by the FDA will be identified.

Content Validation and Disclosures:
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CNE activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

Research To Practice staff and external reviewers — The scientific staff, planners, managers and reviewers for Research To Practice have no relevant conflicts of interest to disclose.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Clovis Oncology and Tesaro Inc.


Marriott Marquis Washington, DC
901 Massachusetts Ave NW
Washington, DC 20001
Hotel Phone: (202) 824-9200

Meeting Room: 
Independence A-E (Meeting Level 4)

The Marriott Marquis Washington, DC is the headquarters hotel for the 2018 ONS Congress and is within a short walking distance (0.2 miles) of the Walter E Washington Convention Center.



TThis activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of ovarian cancer.

There is no registration fee for this event. However, preregistration is highly recommended as seating is limited.

Registration for clinicians in practice

I am a practicing nurse or other healthcare provider involved in the treatment of cancer.

Registration for clinicians in practice »
Registration for other/industry professionals*

For all other professionals, we are unable to confirm seating at this time. If you would like to stand by for participation in this event, please provide your contact information. Should seats become available for the program, we will notify you.

Standby Registration for Other/Industry Professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
To ensure seating, please check in at our onsite registration desk at least one half hour prior to the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program, based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future CME/CNE programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.